Health
2020 Responsibilities for Health Forum co-organized by Infinitus held in Beijing
GUANGZHOU, China, Dec. 23, 2020 /PRNewswire/ -- On December 16, co-hosted by the China Association of Chinese Medicine (CACM) and Health.People.cn, and co-organized by Infinitus (China) Company Ltd. (Infinitus (China)), the 2020 Responsibilities for Health Forum and the launch conference of theCh...
2020-12-23 08:30
380
Transcenta Closes $105 Million in Crossover Financing
HONG KONG and SUZHOU, China, and HANGZHOU, China, Dec. 23, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces today the complet...
2020-12-23 08:00
4347
Irish Technology deployed in South Africa as part of International Music Events re-opening
DUBLIN, Dec. 23, 2020 /PRNewswire/ -- Irish-based Health Passport Europe has partnered with Big Concerts and The Entertainment Group to safely re-open the events industry inSouth Africa, using latest developments in rapid COVID-19 testing and the secure Health Passport Europe mobile technology. ...
2020-12-23 03:15
4289
RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue
Independent DSMB unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 based on review of unblinded safety data from 155 treated patients Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021 Top-line d...
2020-12-22 20:38
5027
Overweight and Obese Subjects Dosed with ASC41 Tablets in a Phase Ib Trial
SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announces today dosing of overweight and obese subjects in a Phase Ib trial of ASC41, an oral tablet,...
2020-12-22 19:18
3594
Ascentage Pharma's Licensee UNITY Biotechnology Announces Milestone Reached in Clinical Development of Treatments for Age-Related Disease, Leading to Milestone Payment
SUZHOU, China and ROCKVILLE, Md., Dec. 22, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its licensee, UNITY Bi...
2020-12-22 18:29
2851
Leapstack has completed tens of millions of yuan in B plus round fundraising, expending intelligent risk control territory
SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- Leapstack, an insur-tech company, has recently announcedtens of millions of yuan B plus round fundraising, leading by Huazhi Capital, a venture capitalist affiliated toAllinpay Network Services, and following by GF Securities Investment. In the past few ye...
2020-12-22 15:50
5301
Home is Where the Heart is for Students, GSA Reveals
Global poll reveals what students really crave this Christmas MELBOURNE, Australia, Dec. 22, 2020 /PRNewswire/ -- 2020 is set to be a festive season like no other, but new research* released today has shown that some things never change, as all students really want is a roast dinner and quality...
2020-12-22 05:00
3150
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004
SEATTLE, Dec. 21, 2020 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced its partnership with Laboratoire Pierre Fabre to manufacture ER-004 – an intra-amniotic drug that will pioneer the treatment of a rare and...
2020-12-21 23:00
3248
Servier to Acquire Agios Pharmaceuticals' Oncology Business
- Transaction includes commercial, clinical and research-stage oncology portfolio and employees for up to$2 billion plus royalties - Includes Agios' marketed medicine TIBSOVO® and a strong oncology pipeline of Phase 3 and early-stage assets - Acquisition in-line with Servier's strategic ambition...
2020-12-21 22:26
2071
LT1001 (Naldebain(R)), an Extended-Release Analgesic Injection, Received Its Second Approval from Singapore's HSA
TAIPEI, Dec. 21, 2020 /PRNewswire/ -- Lumosa Therapeutics is pleased to announce the market approval of LT1001 (Naldebain®), an extended-release analgesic injection, fromSingapore's Health Science Agency (HSA). HSA is regarded as one of the regulatory reference countries in the world. The approv...
2020-12-21 22:08
2450
WuXi Biologics to Acquire Drug Substance Facility in Wuppertal, Germany from Bayer
* The DS facility (MFG19) with 3x1000L perfusion and 6x2000L fed-batch capacity for vaccines and biologics is expected to be GMP ready in late 2021 * Complements WuXi Biologics' existing DP capacity in Germany * Capacity expansion allows WuXi Biologics to meet growing client demand worldwide...
2020-12-21 21:02
3023
BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens
VANCOUVER, British Columbia, Dec. 21, 2020 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTC:LMNGF) ("BioVaxys") announced today that further analysis of the data from a preclinical animal study (also known as the "murine model study") of its haptenized viral protein vaccine tech...
2020-12-21 21:00
3717
Neusoft Medical has reached a strategic cooperation of Sino-Pakistan Healthcare in Pakistan
SHENYANG, China, Dec. 21, 2020 /PRNewswire/ -- Neusoft Medical Systems Co., Ltd. (Neusoft Medical) announced the cloud signing of a memorandum of understanding (MOU) with Dynamic Engineering and Automation Group (DEA) to cooperate in the area of healthcare inPakistan. The partnership intends to ...
2020-12-21 19:18
2295
Sifi Launches Well Fusion, A Novel Presbyopia Correcting System
- Spectacle-free uninterrupted high-quality vision for cataract patients CATANIA, Italy, Dec. 21, 2020 /PRNewswire/ -- SIFI, a leading international eye care company, today announces the launch of theWELL FUSION™ system and the Mini WELL PROXA®intraocular lens, offering a novel solution that prov...
2020-12-21 19:00
4861
Medit announces Straumann Group as a distributor for its intraoral scanners
SEOUL, South Korea, Dec. 21, 2020 /PRNewswire/ -- Medit and Straumann have entered a global distribution partnership for intraoral scanners effective as of January 1st, 2021. This agreement leverages the existing partnership of the two companies for dental lab scanners. The distribution agreeme...
2020-12-21 14:00
3520
Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
SHANGHAI and HONG KONG, Dec. 21, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) submitted by its partner Karyopharm Therapeutics Inc. (Nasdaq...
2020-12-21 08:00
4191
Thermo Scientific Tundra Cryo-TEM Democratizes Cryo-Electron Microscopy, Extends to Users of Any Experience Level
New instrument overcomes cryo-EM barriers, implements artificial intelligence to deliver unparalleled ease-of-use at an affordable price HILLSBORO, Ore., Dec. 21, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced the new Thermo Scientific Tundra ...
2020-12-21 07:00
2402
Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation
SCHAFFHAUSEN, Switzerland, Dec. 18, 2020 /PRNewswire/ -- Occlutech, a privately-held company, announced today that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for Pulmonary Art...
2020-12-18 21:29
4792
Antengene Announces Approval of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM
SHANGHAI and HONG KONG, Dec.18, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncolo...
2020-12-18 15:34
5839
Week's Top Stories
Most Reposted
Senetas and Nokia Announce Strategic Alliance to Secure Mission-Critical Networks for Defence and Government
[Picked up by 312 media titles]
2025-11-27 07:25SpeQtre, the entanglement-based quantum comms demonstrator satellite, is now on orbit
[Picked up by 292 media titles]
2025-11-29 09:00
Pop the 90s: The Westin Surabaya and Four Points Pakuwon Indah Welcomes 2026 with a Spectacular Live Show Featuring Project Pop
[Picked up by 286 media titles]
2025-11-26 10:49
Lincah Acquires Orderfaz to Strengthen Southeast Asia's Social Commerce Infrastructure
[Picked up by 283 media titles]
2025-11-26 09:00
Singapore Hosts Record-Breaking World Robot Olympiad (WRO®) International Final 2025
[Picked up by 282 media titles]
2025-11-27 08:00
Most Read
MINISO Unveils Australia's First and Largest MINISO LAND Flagship at Sydney Chatswood
2025-11-27 18:56
2457
